Cargando…
大剂量地塞米松联合重组人血小板生成素治疗48例成人初治重症原发免疫性血小板减少症的有效性及安全性
OBJECTIVE: To evaluate the efficacy and safety of high dose dexamethasone combined with recombinant human thrombopoietin (rhTPO) in adults with severe newly diagnosed immune thrombocytopenia (ITP). METHODS: Forty-eight adult patients with severe ITP were randomized into two groups, experimental grou...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348189/ https://www.ncbi.nlm.nih.gov/pubmed/27333620 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.010 |
Ejemplares similares
-
重组人血小板生成素用于原发免疫性血小板减少症维持治疗的有效性和安全性——多中心临床研究
Publicado: (2017) -
原发免疫性血小板减少症患者大剂量地塞米松治疗前后色氨酸代谢状态
Publicado: (2017) -
大剂量地塞米松治疗38例原发免疫性血小板减少症患儿的临床研究
Publicado: (2016) -
重组人血小板生成素治疗41例儿童原发免疫性血小板减少症的疗效及安全性
Publicado: (2015) -
重组人血小板生成素治疗92例成人重型原发免疫性血小板减少症的临床观察
Publicado: (2015)